Evidence map›Paper›PMID 35929464›Full record

ArticleJournal of the American Heart Association2022

Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.

Salman Zahid, Mian Tanveer Ud Din, Muhammad Zia Khan, Devesh Rai, Waqas Ullah, Alejandro Sanchez-Nadales, Ahmed Elkhapery, Muhammad Usman Khan, Andrew M Goldsweig, Atul Singla and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Clinical Applications of Artificial Intelligence in Structural Heart Disease.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Salman ZahidDepartment of Medicine Rochester General Hospital Rochester NY.ORCID 0000-0003-2754-9397
Mian Tanveer Ud DinDepartment of Internal Medicine Allegheny Health Network Pittsburgh PA.
Muhammad Zia KhanDivision of Cardiology West Virginia University Heart & Vascular Institute Morgantown WV.ORCID 0000-0001-8473-8069
Devesh RaiDepartment of Medicine Rochester General Hospital Rochester NY.ORCID 0000-0003-1287-6440
Waqas UllahDepartment of Cardiovascular Medicine Jefferson University Hospitals Philadelphia PA.ORCID 0000-0002-4850-0309
Alejandro Sanchez-NadalesDivision of Cardiovascular Medicine Cleveland Clinic Florida Weston FL.
Ahmed ElkhaperyDepartment of Medicine Rochester General Hospital Rochester NY.
Muhammad Usman KhanDivision of Cardiology West Virginia University Heart & Vascular Institute Morgantown WV.ORCID 0000-0002-4452-6317
Andrew M GoldsweigDivision of Cardiovascular Medicine University of Nebraska Medical Center Omaha NE.ORCID 0000-0003-2952-7837
Atul SinglaKaweah Health Medical Center Visalia CA.
Greg FonarrowDivision of Cardiovascular Medicine University of California Los Angeles Los Angeles CA.ORCID 0000-0002-3192-8093
Sudarshan BallaDivision of Cardiology West Virginia University Heart & Vascular Institute Morgantown WV.ORCID 0000-0002-7872-3757
Rochester General Hospital · USWest Virginia University · USAllegheny Health Network · USCleveland Clinic Florida · USJefferson University Hospitals · USKaweah Delta Health Care District · USUniversity of California, Los Angeles · USUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Data on trends, predictors, and outcomes of heart failure (HF) readmissions after transcatheter aortic valve replacement (TAVR) remain limited. Moreover, the relationship between hospital TAVR discharge volume and HF readmission outcomes has not been established. METHODS AND RESULTS The Nationwide Readmission Database was used to identify 30-day readmissions for HF after TAVR from October 1, 2015, to November 30, 2018, using

Indexed as

Aortic Valve StenosisHeart FailureTranscatheter Aortic Valve ReplacementAortic ValveDatabases, FactualHumansPatient ReadmissionRisk FactorsTreatment Outcomeheart failureTAVITAVRtranscatheter aortic valve implantationtranscatheter aortic valve replacement

Identifiers

PMID35929464
PMCPMC9496292
OpenAlexW4289869141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.